* Servicio de Inmunología and
Hematología, Hospital General Universitario Gregorio Marañón, Madrid, Spain; and
Departamento de Inmunología, Centro de Investigaciones Biológicas, Madrid, Spain
Correspondence: Dr. Paloma Sánchez-Mateos, Hospital Gregorio Marañón, Servicio de Inmunología, C/ Dr. Esquerdo 46, 28007 Madrid, Spain. E-mail: inmunoonc{at}hispacom.net
Distinct subsets of dendritic cells (DCs) are present in blood, probably "en route" to different tissues. We have investigated the chemokines and adhesion molecules involved in the migration of myeloid (CD11c+) and plasmacytoid (CD123+) human peripheral blood DCs across vascular endothelium. Among blood DCs, the CD11c+ subset vigorously migrated across endothelium in the absence of any chemotactic stimuli, whereas spontaneous migration of CD123+ DCs was limited. In bare cell migration assays, myeloid DCs responded with great potency to several inflammatory and homeostatic chemokines, whereas plasmacytoid DCs responded poorly to all chemokines tested. In contrast, the presence of endothelium greatly favored transmigration of plasmacytoid DCs in response to CXCL12 (stromal cell-derived factor-1) and CCL5 (regulated on activation, normal T expressed and secreted). Myeloid DCs exhibited a very potent transendothelial migration in response to CXCL12, CCL5, and CCL2 (monocyte chemoattractant protein-1). Furthermore, we explored whether blood DCs acutely switch their pattern of migration to the lymph node-derived chemokine CCL21 (secondary lymphoid-tissue chemokine) in response to microbial stimuli [viral double-stranded (ds)RNA or bacterial CpG-DNA]. A synthetic dsRNA rapidly enhanced the response of CD11c+ DCs to CCL21, whereas a longer stimulation with CpG-DNA was needed to trigger CD123+ DCs responsive to CCL21. Use of blocking monoclonal antibodies to adhesion molecules revealed that both DC subsets used platelet endothelial cell adhesion molecule-1 to move across activated endothelium. CD123+ DCs required ß2 and ß1 integrins to transmigrate, whereas CD11c+ DCs may use integrin-independent mechanisms to migrate across activated endothelium.
Key Words: chemotaxis • myeloid DCs • plasmacytoid DCs • CXCL12
This article has been cited by other articles:
 |
|
 |
|
  G. de la Rosa, D. Yang, P. Tewary, A. Varadhachary, and J. J. Oppenheim Lactoferrin Acts as an Alarmin to Promote the Recruitment and Activation of APCs and Antigen-Specific Immune Responses J. Immunol., May 15, 2008; 180(10): 6868 - 6876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lehner, A. Stilper, P. Morhart, and W. Holter Plasticity of dendritic cell function in response to prostaglandin E2 (PGE2) and interferon-{gamma} (IFN-{gamma}) J. Leukoc. Biol., April 1, 2008; 83(4): 883 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Marchal-Somme, Y. Uzunhan, S. Marchand-Adam, M. Kambouchner, D. Valeyre, B. Crestani, and P. Soler Dendritic Cells Accumulate in Human Fibrotic Interstitial Lung Disease Am. J. Respir. Crit. Care Med., November 15, 2007; 176(10): 1007 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Samaniego, L. Sanchez-Martin, A. Estecha, and P. Sanchez-Mateos Rho/ROCK and myosin II control the polarized distribution of endocytic clathrin structures at the uropod of moving T lymphocytes J. Cell Sci., October 15, 2007; 120(20): 3534 - 3543. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sancho, J. M. Vieira, C. Casalou, M. Mesquita, T. Pereira, B. M. Cavaco, S. Dias, and V. Leite Expression and function of the chemokine receptor CCR7 in thyroid carcinomas. J. Endocrinol., October 1, 2006; 191(1): 229 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sanchez-Sanchez, L. Riol-Blanco, and J. L. Rodriguez-Fernandez The Multiple Personalities of the Chemokine Receptor CCR7 in Dendritic Cells J. Immunol., May 1, 2006; 176(9): 5153 - 5159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Zabel, S. J. Allen, P. Kulig, J. A. Allen, J. Cichy, T. M. Handel, and E. C. Butcher Chemerin Activation by Serine Proteases of the Coagulation, Fibrinolytic, and Inflammatory Cascades J. Biol. Chem., October 14, 2005; 280(41): 34661 - 34666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Li, F. Takeuchi, J.-a. Wang, C. Fuller, G. Pacheco-Rodriguez, J. Moss, and T. N. Darling MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development J. Exp. Med., September 6, 2005; 202(5): 617 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dalgaard, K. J. Beckstrom, F. L. Jahnsen, and J. E. Brinchmann Differential capability for phagocytosis of apoptotic and necrotic leukemia cells by human peripheral blood dendritic cell subsets J. Leukoc. Biol., May 1, 2005; 77(5): 689 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Spight, B. Zhao, M. Haas, S. Wert, A. Denenberg, and T. P. Shanley Immunoregulatory effects of regulated, lung-targeted expression of IL-10 in vivo Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L251 - L265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Zabel, A. M. Silverio, and E. C. Butcher Chemokine-Like Receptor 1 Expression and Chemerin-Directed Chemotaxis Distinguish Plasmacytoid from Myeloid Dendritic Cells in Human Blood J. Immunol., January 1, 2005; 174(1): 244 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Skwor, H. Cho, C. Cassidy, T. Yoshimura, and D. N. McMurray Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages J. Leukoc. Biol., December 1, 2004; 76(6): 1229 - 1239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kaser, S. Kaser, N. C. Kaneider, B. Enrich, C. J. Wiedermann, and H. Tilg Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression Blood, January 15, 2004; 103(2): 648 - 655. [Abstract] [Full Text] [PDF]
|
|
